- Home
- TKLF vs NRXS Comparison
TKLF vs NRXS Comparison
Compare TKLF & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- NRXS
- Stock Information
- Founded
- TKLF 2006
- NRXS 2011
- Country
- TKLF Japan
- NRXS United States
- Employees
- TKLF N/A
- NRXS N/A
- Industry
- TKLF Other Specialty Stores
- NRXS
- Sector
- TKLF Consumer Discretionary
- NRXS
- Exchange
- TKLF Nasdaq
- NRXS Nasdaq
- Market Cap
- TKLF 16.0M
- NRXS 13.0M
- IPO Year
- TKLF 2022
- NRXS 2023
- Fundamental
- Price
- TKLF $3.56
- NRXS $2.49
- Analyst Decision
- TKLF
- NRXS Strong Buy
- Analyst Count
- TKLF 0
- NRXS 1
- Target Price
- TKLF N/A
- NRXS $7.00
- AVG Volume (30 Days)
- TKLF 10.6K
- NRXS 155.9K
- Earning Date
- TKLF 07-15-2025
- NRXS 08-08-2025
- Dividend Yield
- TKLF N/A
- NRXS N/A
- EPS Growth
- TKLF N/A
- NRXS N/A
- EPS
- TKLF 1.70
- NRXS N/A
- Revenue
- TKLF $219,520,631.00
- NRXS $2,934,945.00
- Revenue This Year
- TKLF N/A
- NRXS $138,883.78
- Revenue Next Year
- TKLF N/A
- NRXS $118.59
- P/E Ratio
- TKLF $2.18
- NRXS N/A
- Revenue Growth
- TKLF 32.02
- NRXS 27.52
- 52 Week Low
- TKLF $2.20
- NRXS $1.33
- 52 Week High
- TKLF $8.53
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- TKLF 51.46
- NRXS 49.91
- Support Level
- TKLF $3.20
- NRXS $2.33
- Resistance Level
- TKLF $3.85
- NRXS $2.67
- Average True Range (ATR)
- TKLF 0.20
- NRXS 0.17
- MACD
- TKLF -0.02
- NRXS -0.01
- Stochastic Oscillator
- TKLF 60.93
- NRXS 46.43
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).